Material Information
2024-04-29
The board of directors made resolution for capital injection to Connection Labs Ltd.
Subject: The board of directors made resolution for capital injection to Connection Labs Ltd.
Date of events: 2024/04/29
To which item it meets: paragraph 20
Statement:
1.Name and nature of the underlying assets (if preferred shares, the terms
and conditions of issuance shall also be indicated, e.g., dividend yield,
etc.):Connection Labs Ltd.
2.Date of occurrence of the event:2024/04/29
3.Amount, unit price, and total monetary amount of the transaction:
Volume 60,000,000 shares, unit price is NTD 10, and total
amount of transaction is NTD 600,000,000.
4.Trading counterparty and its relationship with the Company (if the trading
counterparty is a natural person and furthermore is not a related party of
the Company, the name of the trading counterparty is not required to be
disclosed):Connection Labs Ltd.; Subsidiary.
5.Where the trading counterparty is a related party, announcement shall also
be made of the reason for choosing the related party as trading counterparty
and the identity of the previous owner, its relationship with the Company
and the trading counterparty, and the previous date and monetary amount of
transfer: Capital injection.
6.Where an owner of the underlying assets within the past five years has
been a related party of the Company, the announcement shall also include the
date and price of acquisition and disposal by the related party, and its
relationship with the Company at the time of the transaction:
N/A
7.Matters related to the current disposal of creditors' rights (including
types of collaterals of the disposed creditor’s rights; if creditor's
rights over a related party, announcement shall be made of the name of the
related party and the book amount of the creditor's rights, currently being
disposed of, over such related party):N/A
8.Profit or loss from the disposal (not applicable in cases of acquisition
of securities) (those with deferral should provide a table explaining
recognition):N/A
9.Terms of delivery or payment (including payment period and monetary
amount), restrictive covenants in the contract, and other important terms
and conditions:
payment period and monetary amount:payment will be according to
the notice from Connection Labs Ltd.
restrictive covenants in the contract, and other important terms
and conditions: None.
10.The manner of deciding on this transaction (such as invitation to tender,
price comparison, or price negotiation), the reference basis for the
decision on price, and the decision-making unit:The transaction was decided
by Board of Directors, and the price is according to original denomination.
11.Net worth per share of the Company's underlying securities acquired or
disposed of:NTD -7.63.
12.Cumulative no.of shares held (including the current transaction), their
monetary amount, shareholding percentage, and status of any restriction of
rights (e.g., pledges), as of the present moment:
(1) Current cumulatvie volume is 81,722,779 shares and amount is
NTD 802,963,000
(2) Shareholding percentage is 100%.
(3) No restriction of right.
13.Current ratio of securities investment (including the current trade, as
listed in article 3 of Regulations Governing the Acquisition and Disposal of
Assets by Public Companies) to the total assets and equity attributable to
owners of the parent as shown in the most recent financial statement and
working capital as shown in the most recent financial statement as of the
present:
To the total assets is 35.30%, to the shareholder's equity is 162.95%,
and the operating capital is NTD 13,155,276,000.
14.Broker and broker's fee:N/A
15.Concrete purpose or use of the acquisition or disposal:
Long-term investment
16.Any dissenting opinions of directors to the present transaction:N/A
17.Whether the counterparty of the current transaction is
a related party:Yes
18.Date of the board of directors resolution:2024/04/30
19.Date of ratification by supervisors or approval by
the Audit Committee:2024/04/29
20.Whether the CPA issued an unreasonable opinion regarding the current
transaction:N/A
21.Name of the CPA firm:N/A
22.Name of the CPA:N/A
23.Practice certificate number of the CPA:N/A
24.Whether the transaction involved in change of business model:None.
25.Details on change of business model:N/A
26.Details on transactions with the counterparty for the past year and the
expected coming year:None.
27.Source of funds: Equity Fund.
28.Any other matters that need to be specified:
Not yet been resolved by Board Meeting.
While the dispute exists in Board meeting resolution, it will be
disclosed.
BACK >